Most of what gets said about AI and sales performance is anecdotal — a rep swears by a tool, a manager cites a hunch about productivity. A new industry survey puts real numbers behind the claim, and the numbers are bigger than most people expected. They also point to a gap that explains why so many reps who've "tried AI" haven't seen much change in their results.
What the Survey Found
The data comes from AcuityMD's "AI Adoption in MedTech Sales: 2026 Industry Benchmarks and Trends" report, published July 2026, which surveyed 150 sales reps across capital equipment, durable medical equipment, and surgical product sales. Medical Economics covered the findings, and AcuityMD detailed them in its own press release.
The headline finding: medical device sales reps who use AI in their day-to-day work are three times more likely to meet or exceed quota than reps who don't. The inverse held too — reps who missed quota were nearly twice as likely to say they'd never used AI professionally at all.
Despite that gap, adoption is still modest. Only 36% of respondents reported regular or occasional AI use in their day-to-day work. Among that group, though, the time savings were substantial: 92% said AI saved them at least four hours a week.
The Catch: Most Reps Are Using AI for the Wrong Things
Here's where the survey gets interesting. Among reps who have adopted AI, the tool is overwhelmingly being pointed at administrative work, not strategic work:
- Drafting emails — 78%
- Organizing tasks — 69%
- Generating meeting summaries — 67%
- Strategic account research — 19%
- Surfacing insights they wouldn't otherwise have found — 11%
That's a wide gap. Reps are using AI to clear their inbox faster, but almost nobody is using it to figure out which physicians to prioritize or what's actually happening in an account. AcuityMD co-founder Lee Smith framed the opportunity as being "not just efficiency" but better account and opportunity decisions — and right now, most reps aren't there yet.
Why Generic AI Tools Plateau
The survey also found that 69% of AI-using reps rely exclusively on general-purpose tools like ChatGPT. That lines up with the administrative-heavy usage pattern above — a general-purpose chatbot can draft an email or summarize notes, but it has no access to a physician's procedure volume, publication history, or payment relationships. It can't tell a rep who to call; it can only help them write faster once they've already decided.
The more telling data point: reps who met or exceeded quota were more than twice as likely to have access to a company-provided AI solution — built for their industry, not a generic assistant — than reps who missed quota. That's consistent with what this survey identifies as the real bottleneck: it's not whether reps use AI, it's whether the AI they use actually has medical-sales-specific data behind it.
Closing the Strategic Gap
This is exactly the gap RepPrep.ai was built to close. Instead of a blank chat window, RepPrep pulls Medicare and commercial claims data, PubMed publication history, and Sunshine Act/Open Payments records into a single, physician-specific plan — the "strategic account research" and "surfacing insights" categories where this survey found AI adoption is lowest (see "Medicare and Commercial Claims Data: How to Use It to Close More Deals" and "PubMed Data for Sales").
That's also consistent with what we've measured directly: in our own Q4 2025 field trial, reps using even a limited version of RepPrep reported saving 60+ minutes a week and — more relevant to this survey's findings — 80% reported higher call quality, not just faster admin work (see "How RepPrep.ai Saves Medical Sales Reps 5+ Hours Per Week"). The AcuityMD survey and our own data are pointing at the same conclusion from two different directions: generic AI saves reps a few minutes on email. Purpose-built, data-backed AI changes who they call and how prepared they are when they get there — and that's what actually shows up in quota attainment.
What This Means for Reps and Sales Leaders
If you're a rep already using ChatGPT to draft follow-up emails, that's a fine start, but the data suggests it's not what's driving the 3x quota gap. The reps and teams pulling ahead are the ones pointing AI at the decisions that actually matter: which physicians to prioritize, what's changed in an account, and how to walk in prepared. That requires a tool with real data behind it, not just a faster way to write what you already knew to say.
Frequently Asked Questions
What did the AcuityMD survey actually measure?
AcuityMD surveyed 150 medical device sales reps across capital equipment, DME, and surgical product sales in 2026, comparing self-reported AI usage against self-reported quota attainment, along with what specific tasks reps use AI for.
Does using AI guarantee a rep will hit quota?
No — the survey shows correlation, not proof that AI alone causes quota attainment. But the size of the gap (3x) and the fact that quota-hitters were more likely to have access to purpose-built AI tools specifically, not just any AI, both point toward AI use being a meaningful factor rather than a coincidence.
Why do reps using general AI tools like ChatGPT see smaller gains?
General-purpose AI tools have no built-in access to procedure volume, physician publication history, or payment data, so they can only help with tasks like drafting and summarizing. They can't tell a rep which accounts to prioritize or what's changed in a territory — the higher-value work the survey found AI is rarely used for.